Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) on Monday announced termination of the proposed investment into The Physician’s Choice CBD (“PCCBD”) of Phoenix, Arizona, as previously disclosed in April 2019. “I am disappointed to report that after many months of meetings, discussions and attempts to manage an increasingly frustrating process, Chemistree has decided that the proposed … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Announces Cancellation of PCCBD Investment”
Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) on Thursday announced its support for the passage of the Secure and Fair Enforcement Banking Act of 2019 (“SAFE Banking Act”) by the United States House of Representatives. The SAFE Banking Act is anticipated to be voted on by the U.S. Senate by the end of the year. “Chemistree … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Voices Support of SAFE Banking Act”
Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) this morning posted a shareholder update regarding its Washington State assets. Per the update, the company received an encouraging report from the general manager of its Washington state licensee partner that detailed increases from April of 30% in sales, 36% in crop yield and 100% in retail client stores. … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Posts Update on Washington State Assets”
Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) this morning announced that, through a wholly owned U.S. subsidiary, it has finalized its investment into Applied Cannabis Sciences of New Jersey (“ACS”). The investment was previously announced in an April 15, 2019, press release as a letter of intent. According to the update, ACS will submit its … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Completes Investment in Applied Cannabis Sciences of New Jersey”
Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) this morning announced that its partner, Applied Cannabis Sciences of New Jersey (“ACS”), is preparing an application under the Department of Health’s new Request for Applications (“RFA”) program. According to the update, the Department will seek up to 24 cultivation, 30 manufacturing and 54 dispensary endorsements. ACS will apply … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Partner ACS to File NJ Application Under New DOH Program”
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) this morning announced its entry into a funding agreement with The Physician’s Choice CBD LLC (“PCCBD”) of Phoenix, Arizona, which is dedicated to researching, developing and utilizing the highest quality of hemp-derived cannabidiol (“CBD”) in combination with well-studied and effective supplements to assist in supporting and regulating various … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) Enters Agreement to Acquire Ownership Stake in The Physician’s Choice CBD LLC”
Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) this morning provided an update to shareholders on its Washington state assets and Desert Hot Springs, California cultivation facility development. Per the update, Chemistree’s Washington state licensee partner has confirmed further advancements in crucial areas of its cultivation facility, including the appointment of key staff; upgrading of 288 on … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Issues Shareholder Update on Washington Operations and California Cultivation Facility”
Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) this morning announced that its wholly owned U.S. subsidiary, American CHM Investments Inc., has entered a letter of intent to partner with Applied Cannabis Sciences of New Jersey (“ACS”), a New Jersey-based medical retail dispensary applicant in the state’s upcoming round of request for applications, which is anticipated … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Partners with NJ Medical Retail Cannabis License Applicant”
Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) this morning announced its appointment of Sheldon Aberman to the newly-created position of chief cannabis officer. According to the update, Aberman is one of the world’s foremost experts on commercial cannabis cultivation, with expertise, a hands-on approach and product development background as well as decades of experience managing and … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Appoints Industry Expert as Chief Cannabis Officer”
Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) recently announced its appointment of Nicholas J. Zitelli to its board of directors. Zitelli is currently part-owner, director, and chief cannabis officer of Trans High Corporation (“THC”), the parent company for all HIGH TIMES brands, and is also the founder and CEO of the Cannabis Genetics Institute (“CGI”), a … Continue reading “NetworkNewsBreaks – Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) Appoints Cannabis Industry Veteran with Passion, Deep Expertise to its Board”
